1. Home
  2. Analysis
  3. Creon
  4. Korlym

Creon and Korlym drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Creon (pancrelipase (amylase;lipase;protease)) and Korlym (mifepristone). Common drug interactions include blood glucose decreased among females and blood iron decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Creon and Korlym. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

On Jul, 06, 2026

17 people who take Creon and Korlym together, and have interactions are studied.

Creon and Korlym drug interactions.

What are the common drug interactions of Creon and Korlym, by gender? *:

female:

  1. Blood glucose decreased
  2. Blood potassium increased
  3. Cellulitis (infection under the skin)
  4. Mastitis (inflammation of breast)
  5. Blood pressure increased
  6. Uterine cyst
  7. Asthenia (weakness)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hypokalaemia (low potassium)
  10. Localised infection (infection at the single location)

male:

  1. Blood iron decreased
  2. Blood potassium increased
  3. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  4. Arteriosclerosis (thickening and hardening of arteries)
  5. Fatigue (feeling of tiredness)
  6. Haemorrhage (bleeding)
  7. Mobility decreased (ability to move is reduced)
  8. Muscular weakness (muscle weakness)
  9. Peripheral coldness
  10. Platelet count increased

What are the common drug interactions of Creon and Korlym, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Blood potassium increased
  2. Blood iron decreased
  3. Pain in extremity
  4. Blood glucose decreased
  5. Blood pressure increased
  6. Uterine cyst
  7. Oedema (fluid collection in tissue)
  8. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Cushing's Syndrome (obesity, a rounded face, increased fat): 17 people, 100.00%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Creon and Korlym?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Creon and Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Korlym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) and mifepristone (the active ingredients of Creon and Korlym, respectively), and Creon and Korlym (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.